Skip to results
Modify your search
NARROW
1-20 of 33
Authors: Curtis Cooper
Journal Article
Rapid Hepatitis C Virus Engagement and Treatment in Hospitalized Patients Get access
Clinical Infectious Diseases, ciae574, https://doi.org/10.1093/cid/ciae574
Published: 21 November 2024
Journal Article
Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection
The Journal of Infectious Diseases, Volume 231, Issue 1, 15 January 2025, Pages e101–e112, https://doi.org/10.1093/infdis/jiae487
Published: 17 October 2024
Journal Article
Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study
Open Forum Infectious Diseases, Volume 11, Issue 5, May 2024, ofae239, https://doi.org/10.1093/ofid/ofae239
Published: 25 April 2024
Journal Article
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e702–e709, https://doi.org/10.1093/cid/ciac540
Published: 05 July 2022
Journal Article
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
The Journal of Infectious Diseases, Volume 227, Issue 7, 1 April 2023, Pages 838–849, https://doi.org/10.1093/infdis/jiac229
Published: 07 June 2022
Journal Article
Routinized Syphilis Screening Among Men Living With Human Immunodeficiency Virus: A Stepped Wedge Cluster Randomized Controlled Trial
Clinical Infectious Diseases, Volume 74, Issue 5, 1 March 2022, Pages 846–853, https://doi.org/10.1093/cid/ciab582
Published: 27 June 2021
Journal Article
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry
Clinical Infectious Diseases, Volume 72, Issue 11, 1 June 2021, Pages e799–e805, https://doi.org/10.1093/cid/ciaa1510
Published: 02 March 2021
Journal Article
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
Clinical Infectious Diseases, Volume 73, Issue 3, 1 August 2021, Pages 468–477, https://doi.org/10.1093/cid/ciaa702
Published: 05 June 2020
Journal Article
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1392–1400, https://doi.org/10.1093/cid/ciaa253
Published: 12 March 2020
Journal Article
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Clinical Infectious Diseases, Volume 71, Issue 7, 1 October 2020, Pages e115–e124, https://doi.org/10.1093/cid/ciz1089
Published: 02 November 2019
Journal Article
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
Clinical Infectious Diseases, Volume 71, Issue 2, 15 July 2020, Pages 363–371, https://doi.org/10.1093/cid/ciz833
Published: 28 August 2019
Journal Article
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Clinical Infectious Diseases, Volume 70, Issue 11, 1 June 2020, Pages 2369–2376, https://doi.org/10.1093/cid/ciz633
Published: 11 July 2019
Journal Article
Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV Coinfection
Open Forum Infectious Diseases, Volume 6, Issue 7, July 2019, ofz318, https://doi.org/10.1093/ofid/ofz318
Published: 03 July 2019
Journal Article
Eliminating Hepatitis C (and the Unknowns) in the Human Immunodeficiency Virus Coinfected
Clinical Infectious Diseases, Volume 70, Issue 10, 15 May 2020, Pages 2141–2142, https://doi.org/10.1093/cid/ciz604
Published: 02 July 2019
Journal Article
Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care
Open Forum Infectious Diseases, Volume 6, Issue 3, March 2019, ofz055, https://doi.org/10.1093/ofid/ofz055
Published: 13 February 2019
Journal Article
Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study Cohort
Open Forum Infectious Diseases, Volume 6, Issue 1, January 2019, ofy273, https://doi.org/10.1093/ofid/ofy273
Published: 24 January 2019
Journal Article
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials
Open Forum Infectious Diseases, Volume 5, Issue 11, November 2018, ofy248, https://doi.org/10.1093/ofid/ofy248
Published: 27 September 2018
Journal Article
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study
Clinical Infectious Diseases, Volume 65, Issue 1, 1 July 2017, Pages 13–19, https://doi.org/10.1093/cid/cix289
Published: 23 May 2017
Journal Article
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
Clinical Infectious Diseases, Volume 64, Issue 9, 1 May 2017, Pages 1154–1162, https://doi.org/10.1093/cid/cix126
Published: 12 February 2017
Journal Article
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir
Clinical Infectious Diseases, Volume 63, Issue 4, 15 August 2016, Pages 528–531, https://doi.org/10.1093/cid/ciw349
Published: 25 May 2016
